
Ask a doctor about a prescription for EXEMESTANE RATIOPHARM 25 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Exemestane ratiopharm 25 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
-Keep this leaflet, you may need to read it again.
-If you have any further questions, ask your doctor or pharmacist.
-This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
-If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack and other information:
6 Contents of the pack and further information
This medicine is called Exemestane ratiopharm. Exemestane ratiopharm belongs to a group of medicines called aromatase inhibitors. These medicines interfere with a substance called aromatase, which is necessary for producing female sex hormones, estrogens, especially in postmenopausal women. The reduction of estrogen levels in the body is a way of treating hormone-dependent breast cancer.
Exemestane ratiopharm is used to treat hormone-dependent breast cancer in early stages in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen.
It is also used to treat advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatment has not been effective enough.
Do not takeExemestane ratiopharm
Warnings and precautions
Talk to your doctor or pharmacist before starting to take Exemestane ratiopharm
Taking Exemestane ratiopharm with other medicines
Tell your doctor if you are using or have recently used or may need to use any other medicines, including those obtained without a prescription.
Exemestane ratiopharm should not be taken at the same time as hormone replacement therapy (HRT). The following medicines should be used with caution if you are being treated with Exemestane ratiopharm. Tell your doctor if you are taking any of these medicines:
Pregnancy, breast-feeding, and fertility
Do not take Exemestane ratiopharm if you are pregnant or breast-feeding.
Tell your doctor if you are pregnant or think you may be pregnant.
Talk to your doctor about contraceptive measures if there is any chance you may become pregnant.
Driving and using machines
If you feel dizzy, drowsy, or tired while being treated with Exemestane ratiopharm, do not drive or operate machinery.
Follow exactly the administration instructions of this medicine as indicated by your doctor. If in doubt, consult your doctor or pharmacist again. Your doctor will tell you how to take Exemestane ratiopharm and for how long.
Adults and elderly
The normal dose is one 25 mg film-coated tablet per day.
Exemestane ratiopharm film-coated tablets should be taken orally after a meal, approximately at the same time each day.
Use in children and adolescents
Exemestane ratiopharm is not suitable for use in children and adolescents.
If you take more Exemestane ratiopharm than you should
If you accidentally ingest too many tablets, contact your doctor immediately or go directly to the emergency department of the nearest hospital or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. Show them the Exemestane ratiopharm packaging.
If you forget to take Exemestane ratiopharm
Do not take a double dose to make up for forgotten doses.
If you forget to take a tablet, take it as soon as you remember. If it is near the time of the next dose, take it at the usual time.
If you stop taking Exemestane ratiopharm
Do not stop treatment even if you do not feel well, unless your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Exemestane ratiopharm can cause side effects, although not everybody gets them. In general, Exemestane ratiopharm is well tolerated, and the following side effects observed in patients treated with Exemestane ratiopharm are mainly mild or moderate in nature. Most side effects are associated with the reduction of estrogens (such as hot flashes).
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from the available data).
If you have had a blood test, you may have seen that there have been changes in liver function. There may be changes in the number of certain blood cells (lymphocytes) and platelets (cells that produce blood clotting) circulating in the blood, especially in patients with pre-existing lymphopenia (decrease in lymphocytes in the blood).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in the Spanish Medicines Agency's website: www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Exemestane ratiopharm
The active ingredient is exemestane. Each film-coated tablet contains 25 mg of exemestane.
The other ingredients are:
Core of the tablet:
Mannitol, Copovidone, Crospovidone, Microcrystalline cellulose silicate, Sodium starch glycolate (Type A), Magnesium stearate.
Coating:
Hypromellose, Macrogol 400, Titanium dioxide (E171)
Appearance of the product and packaging
White to off-white, round, convex film-coated tablets with "25" on one side and smooth on the other side.
Exemestane ratiopharm is available in pack sizes of: 30 film-coated tablets.
Marketing authorisation holder and manufacturer
Teva Pharma, S.L.U.
C/ Anabel Segura 11, Edificio Albatros B, 1ª planta
28108 Alcobendas, Madrid (Spain)
Manufacturer
EirGen Pharma Ltd.
Westside Business Park, Old Kilmeaden Road, Waterford
Ireland
or
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
or
TEVA Pharmaceutical Works Private Limited Company
H-2100 Gödöllo, Táncsics Mihály út 82
Hungary
or
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
or
Teva Pharma B.V.,
Swensweg 5, 2031 GA Haarlem
Netherlands
Date of last revision of this leaflet: March 2016
"Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/"
The average price of EXEMESTANE RATIOPHARM 25 mg FILM-COATED TABLETS in December, 2025 is around 96.66 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for EXEMESTANE RATIOPHARM 25 mg FILM-COATED TABLETS – subject to medical assessment and local rules.